Completed Heart, Stroke & Blood Digestion, Kidneys & Other Organs

Risk-benefit assessment of snakebite antivenoms

Funder Wellcome Charity-funded
Associated organisations Agencia estatal Consejo Superior de Investigaciones Científicas · World Health Organization, Switzerland Europe PMC affiliations are not treated as award recipients or mapped locations.
Funding £3.0M
Period Jul 2021 — Sept 2022

About this grant

This summary is based on the grant title only — the full abstract was not available.

This record describes a research project funded by Wellcome. Europe PMC lists researcher affiliations for this record, not a grant-level recipient.

View the original record at the funder ↗

Researchers

Carmen Rodriguez Hernandez (EPMC Awardee)Juan Calvete (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Antivenom Market study: Burden of Snakebite and its Situation Analysis in ASEAN countries
Antivenom clinical trial development
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
Antivenom Clinical Methodology Development
Multi-centre Antivenom Trial in Africa

Original classification

Discretionary Award - Snakebite

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.